Logo

2019 Vol.37, N°3 - Suppl.118 - Table of contents

Sjögren’s syndrome 2019

Sjögren’s syndrome 2019

Second Annual Supplement on Sjögren’s syndrome

Guest Editors: M. Bombardieri, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas

Purchase all articles

PageArticle - [Author(s)]PDFAbs.
One year in review

CER12551
2019,37,3,Suppl.118
Pg. 0003-0015

One year in review 2019: Sjögren’s syndrome
G. Cafaro, C. Croia, O. Argyropoulou, M. Leone, M. Orlandi, F. Finamore, A. Cecchettini, F. Ferro, C. Baldini, E. Bartoloni › Free to View
Rheumatology ArticleRheumatology Abstract
Editorials

CER12472
2019,37,3,Suppl.118
Pg. 0016-0018

The necessity of novel biomarkers in primary Sjögren’s syndrome
A. Tzioufas, A. Goules › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12398
2019,37,3,Suppl.118
Pg. 0019-0023

The Big Data Sjögren Consortium: a project for a new data science era
N. Acar-Denizli, B. Kostov, M. Ramos-Casals
on behalf of the Sjögren Big Data Consortium › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12442
2019,37,3,Suppl.118
Pg. 0024-0026

Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjögren’s syndrome
S. De Vita, A. Zabotti, S. Gandolfo › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12559
2019,37,3,Suppl.118
Pg. 0027-0028

Variation in primary Sjögren's syndrome care among European countries
C. Seghieri, E. Lupi, T. Exarchos, F. Ferro, A. Tzioufas, C. Baldini › Free to View
Rheumatology ArticleRheumatology Abstract
Aetiopathogenesis

CER11454
2019,37,3,Suppl.118
Pg. 0029-0035

α-enolase is an antigenic target in primary Sjögren’s syndrome
E. Olivares-Martínez, D. Hernández-Ramírez, C. Núñez-Álvarez, L. Llorente, G. Hernandez-Molina › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11534
2019,37,3,Suppl.118
Pg. 0036-0041

Angiogenic T cells in primary Sjögren’s syndrome: a double-edged sword?
A. Alunno, L. Ibba-Manneschi, O. Bistoni, S. Cipriani, F. Topini, R. Gerli, M. Manetti › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11811
2019,37,3,Suppl.118
Pg. 0042-0048

Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren’s syndrome patients
M. van Ginkel, E. Haacke, H. Bootsma, S. Arends, J. van Nimwegen, G. Verstappen, F. Spijkervet, A. Vissink, B. van der Vegt, F. Kroese › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11677
2019,37,3,Suppl.118
Pg. 0049-0054

Differential expression of miR-17-92 cluster among varying histological stages of minor salivary gland in patients with primary Sjögren’s syndrome
T. Yan, J. Shen, J. Chen, M. Zhao, H. Guo, Y. Wang › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12383
2019,37,3,Suppl.118
Pg. 0055-0064

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren’s syndrome
S. Gandolfo, M. Bulfoni, C. Fabro, S. Russi, D. Sansonno, C. Di Loreto, D. Cesselli, S. De Vita › Free to View
Rheumatology ArticleRheumatology Abstract
Clinical aspects

CER11446
2019,37,3,Suppl.118
Pg. 0065-0069

Prevalence of sicca syndrome in the Peruvian population
L. Moreno-Quispe, I. Velarde-Grados, M. Guzmán-Avalos, L. De Arriba, R. López-Pintor › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11455
2019,37,3,Suppl.118
Pg. 0070-0077

Evaluation of salivary and plasma microRNA expression in patients with Sjögren’s syndrome, and correlations with clinical and ultrasonographic outcomes
R. Talotta, V. Mercurio, S. Bongiovanni, C. Vittori, L. Boccassini, F. Rigamonti, A. Batticciotto, F. Atzeni, D. Trabattoni, P. Sarzi-Puttini, M. Biasin › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11729
2019,37,3,Suppl.118
Pg. 0078-0082

A two-phase cohort study of the sleep phenotype within primary Sjögren’s syndrome and its clinical correlates
I. Lewis, K. Hackett, W. Ng, J. Ellis, J. Newton › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12121
2019,37,3,Suppl.118
Pg. 0083-0089

Trends in employment and hospitalisation in patients with Sjögren's syndrome 1996-2016: results from the German National database
J. Callhoff, K. Thiele, T. Dörner, A. Zink, J. Richter, J. Henes, K. Albrecht › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12250
2019,37,3,Suppl.118
Pg. 0090-0096

Enhancing medical data quality through data curation: a case study in primary Sjögren’s syndrome
V. Pezoulas, K. Kourou, F. Kalatzis, T. Exarchos, A. Venetsanopoulou, E. Zampeli, S. Gandolfo, F. Skopouli, S. De Vita, A. Tzioufas, D. Fotiadis › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12343
2019,37,3,Suppl.118
Pg. 0097-0106

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
S. Retamozo, N. Acar-Denizli, A. Rasmussen, I. Horváth, C. Baldini, R. Priori, P. Sandhya, G. Hernandez-Molina, B. Armagan, S. Praprotnik, M. Kvarnstrom, R. Gerli, A. Sebastian, R. Solans, M. Rischmueller, S. Pasoto, V. Valim, G. Nordmark, A. Kruize, H. Nakamura, B. Hofauer, R. Giacomelli, V. Fernandes Moça Trevisani, V. Devauchelle-Pensec, F. Atzeni, T. Gheita, S. Consani-Fernández, A. Szántó, K. Sivils, A. Gattamelata, D. Danda, L. Kilic, E. Bartoloni, S. Bombardieri, J. Sánchez-Guerrero, M. Wahren-Herlenius, X. Mariette, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12486
2019,37,3,Suppl.118
Pg. 0107-0113

Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren’s syndrome: data from a nationwide cohort for Sjögren’s syndrome in Korea
Y. Park, J. Lee, J. Koh, Y. Sung, S. Lee, J. Choe, S. Shim, J. Kim, S. Kwon, H. Kim, S. Chung, S. Park, S. Kwok › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12399
2019,37,3,Suppl.118
Pg. 0114-0122

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)
M. Ramos-Casals, A. Maria, M. Suárez-Almazor, O. Lambotte, B. Fisher, G. Hernández-Molina, P. Guilpain, X. Pundole, A. Flores-Chávez, C. Baldini, C. Bingham III, P. Brito-Zerón, J. Gottenberg, M. Kostine, T. Radstake, T. Schaeverbeke, H. Schulze-Koops, L. Calabrese, M. Khamashta, X. Mariette
on behalf of the ICIR › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12524
2019,37,3,Suppl.118
Pg. 0123-0132

Renal involvement in primary Sjögren’s syndrome: natural history and treatment outcome
A. Goules, D. Geetha, L. Arend, A. Baer › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12558
2019,37,3,Suppl.118
Pg. 0133-0139

Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren’s syndrome: a novel pathogenetic scenario?
E. Bartoloni, C. Baldini, F. Ferro, A. Alunno, F. Carubbi, G. Cafaro, S. Bombardieri, R. Gerli, E. Grossi › Free to View
Rheumatology ArticleRheumatology Abstract
Diagnosis

CER12104
2019,37,3,Suppl.118
Pg. 0140-0145

Evaluation of salivary gland ultrasonography in primary Sjögren's syndrome: does it reflect clinical activity and outcome of the disease?
N. Inanc, Y. Şahinkaya, G. Mumcu, F. Türe Özdemir, A. Paksoy, Z. Ertürk, H. Direskeneli, G. Bruyn › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12487
2019,37,3,Suppl.118
Pg. 0146-0152

Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjögren's syndrome
A. Zabotti, S. Zandonella Callegher, S. Gandolfo, F. Valent, I. Giovannini, E. Cavallaro, M. Lorenzon, S. De Vita › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER12363
2019,37,3,Suppl.118
Pg. 0153-0158

Assessment of major salivary gland ultrasonography in Sjögren’s syndrome. A comparison between bedside and post-examination evaluations
D. Hammenfors, H. Causevic, J. Assmus, J. Brun, R. Jonsson, M. Jonsson › Free to View
Rheumatology ArticleRheumatology Abstract
Treatment

CER11500
2019,37,3,Suppl.118
Pg. 0159-0166

Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease
M. Lanzillotta, E. Della-Torre, R. Milani, E. Bozzolo, E. Bozzalla-Cassione, L. Rovati, P. Arcidiacono, S. Partelli, M. Falconi, F. Ciceri, L. Dagna › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
Reviews

CER12011
2019,37,3,Suppl.118
Pg. 0167-0174

Present and novel biologic drugs in primary Sjögren's syndrome
S. Fasano, D. Isenberg › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11919
2019,37,3,Suppl.118
Pg. 0175-0184

Sjögren’s syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts
A. Goules, T. Exarchos, V. Pezoulas, K. Kourou, A. Venetsanopoulou, S. De Vita, D. Fotiadis, A. Tzioufas › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12504
2019,37,3,Suppl.118
Pg. 0185-0191

Type I interferon signature in Sjögren’s syndrome: pathophysiological and clinical implications
N. Marketos, I. Cinoku, A. Rapti, C. Mavragani › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12552
2019,37,3,Suppl.118
Pg. 0192-0198

The kaleidoscope of neurological manifestations in primary Sjögren’s syndrome
A. Alunno, F. Carubbi, E. Bartoloni, P. Cipriani, R. Giacomelli, R. Gerli › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12557
2019,37,3,Suppl.118
Pg. 0199-0208

Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren’s syndrome
S. Gandolfo, S. De Vita › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12461
2019,37,3,Suppl.118
Pg. 0209-0216

Animal models of Sjögren’s syndrome: an update
F. Xiao, M. Han, X. Wang, X. Gong, E. Huang, Z. Zhu, F. Zhao, Y. Zhao, Q. Jiang, L. Lu › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12517
2019,37,3,Suppl.118
Pg. 0217-0224

B cell depletion with rituximab in the treatment of primary Sjögren’s syndrome: what have we learnt?
S. Grigoriadou, F. Chowdhury, E. Pontarini, A. Tappuni, S. Bowman, M. Bombardieri › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12375
2019,37,3,Suppl.118
Pg. 0225-0233

Sjögren’s syndrome is not a risk factor for periodontal disease: a systematic review
F. Maarse, D. Jager, S. Alterch, A. Korfage, T. Forouzanfar, A. Vissink, H. Brand › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12528
2019,37,3,Suppl.118
Pg. 0234-0239

Genetics in Sjögren’s syndrome: where we are and where we go
V. Harris, R. Scofield, K. Sivils › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER12560
2019,37,3,Suppl.118
Pg. 0240-0248

Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren’s syndrome
A. Cecchettini, F. Finamore, I. Puxeddu, F. Ferro, C. Baldini › Free to View
Rheumatology ArticleRheumatology Abstract
Case Report

CER12339
2019,37,3,Suppl.118
Pg. 0249-0251

Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia
O. Argyropoulou, L. Chatzis, D. Rontogianni, A. Tzioufas › Free to View
Rheumatology ArticleRheumatology Abstract
Letters to the Editor

CER11735
2019,37,3,Suppl.118
Pg. 0252-0253

Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren’s syndrome?
D. Spoerl, P. Roux-Lombard › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11741
2019,37,3,Suppl.118
Pg. 0254-0256

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome
F. Vincent, M. Bubicich, S. Downie-Doyle, F. Mackay, E. Morand, M. Rischmueller › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract